Brain

2024 PHBS-CJBS Global Pitch Competition Grand Final Held

SHENZHEN, China, Dec. 10, 2024 /PRNewswire/ -- The 2024 PHBS-CJBS Global Pitch Competition, jointly hosted by Peking University HSBC Business School…

1 year ago

New ALS Association-Led Research Finds Specialists Diagnose ALS Twice as Fast as General Neurologists

Groundbreaking thinkALS™ Tool Empowers Providers to Identify and Refer Patients Quicker ARLINGTON, Va., Dec. 10, 2024 /PRNewswire/ -- It can take…

1 year ago

Neuropathy Action Foundation Launches White Paper on the Promise and Potential Hazards of Artificial Intelligence (AI) for Neuropathy

NAF calls for increased awareness and advocacy around use of AI to prevent potential abuses SANTA ANA, Calif., Dec. 10,…

1 year ago

MDClone recognized as one of Modern Healthcare’s Best in Business

CHICAGO, Dec. 9, 2024 /PRNewswire/ -- MDClone, a leading data exploration and synthetic data company, is proud to announce that it…

1 year ago

Cala® Health Closes Oversubscribed $50 Million Financing To Propel Growth

SAN MATEO, Calif., Dec. 9, 2024 /PRNewswire/ -- Cala Health, the non-invasive bioelectronic medicine leader, today announced it has completed…

1 year ago

Liraglutide Processed with DehydraTECH to be Studied in Human GLP-1 Study #5

Positive results in recent animal study strongly support first-ever human investigation for DehydraTECH-liraglutide KELOWNA, BC / ACCESSWIRE / December 9,…

1 year ago

Tonix’s TNX 102-SL Could Offer New Hope of Pain Relief Without Narcotics for Fibromyalgia Sufferers

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding…

1 year ago

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

SEATTLE and VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical…

1 year ago

BioGene Therapeutics Appoints Patroski J. Lawson to Board of Directors

Vancouver, British Columbia--(Newsfile Corp. - December 9, 2024) - PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE:18H) ("PreveCeutical" or the…

1 year ago